eShowcase: ClearTrial 2.0
Web-based dashboard places clinical trial designers squarely in the driver's seat
Web-based dashboard places clinical trial designers squarely in the driver's seat
ClearTrial, LLC (Oakbrook Terrace, IL) has released version 2.0 of its clinical trial operations planning software to help biopharm companies and CROs plan, budget, and optimize the operational design of clinical trials.
The heart of this latest version is a Web-based "dashboard" that offers a view of monthly budgets, accruals forecasts, study metrics, cycle-time dates, costs, and FTE/resource requirements. Also new is support for multiple outsourcing strategies, full-service outsourcing, hybrid studies, staff augmentation, and internal studies.
Other adornments to this version include the ability to compare cost and timelines between internal studies and outsourced ones, as well as assign study tasks to multiple service providers by function or country. Collaborative planning is also now possible between departments, business units, and strategic partners.
ClearTrial 2.0 is a J2EE-compliant, native Web-based application running over an Oracle database.
ClearTrial, LLC, (630) 424-1601, www.cleartrial.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer
June 10th 2025In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.
